Brenntag (BNR) Given a €61.00 Price Target at Commerzbank

Share on StockTwits

Brenntag (FRA:BNR) has been assigned a €61.00 ($70.93) target price by equities researchers at Commerzbank in a research report issued to clients and investors on Wednesday. The brokerage presently has a “buy” rating on the stock. Commerzbank’s target price suggests a potential upside of 36.53% from the stock’s previous close.

Several other equities analysts also recently commented on BNR. Kepler Capital Markets set a €63.00 ($73.26) price objective on shares of Brenntag and gave the company a “buy” rating in a research note on Wednesday. equinet set a €59.80 ($69.53) price objective on shares of Brenntag and gave the company a “buy” rating in a research note on Wednesday. Berenberg Bank set a €60.00 ($69.77) price objective on shares of Brenntag and gave the company a “neutral” rating in a research note on Wednesday, August 8th. Warburg Research set a €60.00 ($69.77) price objective on shares of Brenntag and gave the company a “buy” rating in a research note on Wednesday, August 8th. Finally, UBS Group set a €50.00 ($58.14) price objective on shares of Brenntag and gave the company a “neutral” rating in a research note on Monday, August 20th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have assigned a buy rating to the company. Brenntag presently has an average rating of “Buy” and an average target price of €58.49 ($68.01).

Shares of FRA:BNR opened at €44.68 ($51.95) on Wednesday. Brenntag has a 12 month low of €43.06 ($50.07) and a 12 month high of €56.25 ($65.41).

Brenntag Company Profile

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

Read More: Analyst Ratings

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply